DK1615628T3 - Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden - Google Patents

Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden

Info

Publication number
DK1615628T3
DK1615628T3 DK04726478T DK04726478T DK1615628T3 DK 1615628 T3 DK1615628 T3 DK 1615628T3 DK 04726478 T DK04726478 T DK 04726478T DK 04726478 T DK04726478 T DK 04726478T DK 1615628 T3 DK1615628 T3 DK 1615628T3
Authority
DK
Denmark
Prior art keywords
skin
patch
active substance
person
medically active
Prior art date
Application number
DK04726478T
Other languages
Danish (da)
English (en)
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33154271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1615628(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1615628T3 publication Critical patent/DK1615628T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Spectrometry And Color Measurement (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Materials For Medical Uses (AREA)
DK04726478T 2003-04-17 2004-04-08 Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden DK1615628T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10317692A DE10317692A1 (de) 2003-04-17 2003-04-17 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
PCT/EP2004/003748 WO2004091590A1 (de) 2003-04-17 2004-04-08 Medizinische wirkstoffpflaster mit verringerter optischer auffälligkeit auf der haut

Publications (1)

Publication Number Publication Date
DK1615628T3 true DK1615628T3 (da) 2009-04-06

Family

ID=33154271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04726478T DK1615628T3 (da) 2003-04-17 2004-04-08 Plaster med medicinsk aktivt stof og forringet optisk synlighed på huden

Country Status (22)

Country Link
US (3) US10653636B2 (enExample)
EP (1) EP1615628B1 (enExample)
JP (2) JP5733875B2 (enExample)
KR (1) KR101052127B1 (enExample)
CN (1) CN100450472C (enExample)
AT (1) ATE415954T1 (enExample)
AU (1) AU2004229159B2 (enExample)
BR (1) BRPI0409889B8 (enExample)
CA (1) CA2522962C (enExample)
CY (1) CY1108832T1 (enExample)
DE (2) DE10317692A1 (enExample)
DK (1) DK1615628T3 (enExample)
ES (1) ES2320550T3 (enExample)
IL (1) IL171399A (enExample)
MX (1) MXPA05010935A (enExample)
NZ (1) NZ543195A (enExample)
PL (1) PL1615628T3 (enExample)
PT (1) PT1615628E (enExample)
RU (1) RU2336866C2 (enExample)
SI (1) SI1615628T1 (enExample)
WO (1) WO2004091590A1 (enExample)
ZA (1) ZA200507034B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut
DE102005010255A1 (de) * 2005-03-07 2006-09-14 Lts Lohmann Therapie-Systeme Ag Faserfreies transdermales therapeutisches System und Verfahren zu seiner Herstellung
RU2367577C1 (ru) 2005-08-12 2009-09-20 Рик Б. ЙЕГЕР Система и способ для нанесения изменяющего отражательную способность вещества в целях улучшения визуальной привлекательности человеческой кожи
US8942775B2 (en) 2006-08-14 2015-01-27 Tcms Transparent Beauty Llc Handheld apparatus and method for the automated application of cosmetics and other substances
US8184901B2 (en) 2007-02-12 2012-05-22 Tcms Transparent Beauty Llc System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image
JP5237112B2 (ja) * 2006-12-01 2013-07-17 日東電工株式会社 経皮吸収製剤
KR101408454B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법
JP2010519185A (ja) 2007-02-12 2010-06-03 リック ビー． イェーガー， 作用物質を静電気的に人の皮膚に塗布するためのシステムおよび方法
US10092082B2 (en) 2007-05-29 2018-10-09 Tcms Transparent Beauty Llc Apparatus and method for the precision application of cosmetics
RU2483729C2 (ru) * 2008-05-30 2013-06-10 Нитто Денко Корпорейшн Чрескожно абсорбируемый препарат
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
EP3310327A2 (en) * 2015-06-22 2018-04-25 Johnson & Johnson Consumer Inc. Method for providing a benefit to skin
JP7398750B2 (ja) * 2019-02-28 2023-12-15 パナソニックＩｐマネジメント株式会社 画像処理装置、画像処理方法およびシート

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE7529365U (de) 1976-01-08 Beiersdorf Ag, 2000 Hamburg Wund schnell verband
JPS55111416A (en) * 1979-02-20 1980-08-28 Taisho Pharmaceut Co Ltd Paster
US4594276A (en) * 1984-04-09 1986-06-10 Minnesota Mining And Manufacturing Company Printed, removable body tattoos on a translucent substrate
JPH0739566B2 (ja) 1986-02-21 1995-05-01 積水化学工業株式会社 医療用粘着テープもしくはシートの製造方法
US5004610A (en) * 1988-06-14 1991-04-02 Alza Corporation Subsaturated nicotine transdermal therapeutic system
US5004510A (en) * 1989-01-30 1991-04-02 Panzhihua Iron & Steel Co. Process for manufacturing high strength railroad rails
DE4030465C2 (de) * 1990-09-26 1994-06-01 Ruschke Mona Pflaster
US5120325A (en) * 1991-06-12 1992-06-09 Fleshtones Products Co., Inc. Color-matched sterile adhesive bandages containing melanin-like pigment composition
CA2075517C (en) * 1992-04-01 1997-03-11 John Wick Transdermal patch incorporating a polymer film incorporated with an active agent
US5264219A (en) * 1992-08-07 1993-11-23 Minnesota Mining And Manufacturing Company Transdermal drug delivery backing
JPH07206624A (ja) 1994-01-20 1995-08-08 Shiseido Co Ltd 皮膚外用剤
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
DE19519593C1 (de) * 1995-05-29 1996-08-29 Horstmann Michael Transdermales Therapeutisches System mit druckfarbenfreier Identifikation und Verfahren zu seiner Herstellung
TR199802659T2 (xx) * 1996-06-20 1999-03-22 Lavipharm S.A. Topikal akne tedavisi i�in bir ara� ve tedavi y�ntemi.
US6025535A (en) * 1996-10-28 2000-02-15 The Procter & Gamble Company Topsheet for absorbent articles exhibiting improved masking properties
JPH11116470A (ja) * 1997-08-12 1999-04-27 Takeda Chem Ind Ltd イデベノン含有経皮投与製剤
HUP0104728A3 (en) * 1998-12-18 2006-07-28 Alza Corp Mountain View Transparent transdermal nicotine delivery device
DE19912623A1 (de) * 1999-03-20 2000-09-28 Lohmann Therapie Syst Lts Verfahren zur Erhöhung der Stabilität bei Lagerung und/oder Anwendung lichtempfindlicher therapeutischer Systeme oder deren Bestandteile
AU2000242314B2 (en) * 2000-04-12 2005-11-03 The Procter & Gamble Company Pre-formed sheet devices suitable for topical application
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US8586079B2 (en) * 2002-06-21 2013-11-19 Graphic Productions Inc. Promotional simulation for transdermal patch sampler
DE10317692A1 (de) * 2003-04-17 2004-11-11 Lts Lohmann Therapie-Systeme Ag Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut

Also Published As

Publication number Publication date
ATE415954T1 (de) 2008-12-15
JP2012092133A (ja) 2012-05-17
JP5733875B2 (ja) 2015-06-10
AU2004229159B2 (en) 2010-01-28
JP2006523637A (ja) 2006-10-19
EP1615628B1 (de) 2008-12-03
US20190160017A1 (en) 2019-05-30
BRPI0409889A (pt) 2006-05-23
AU2004229159A1 (en) 2004-10-28
BRPI0409889B1 (pt) 2019-12-17
US10646453B2 (en) 2020-05-12
EP1615628A1 (de) 2006-01-18
IL171399A (en) 2015-02-26
CA2522962A1 (en) 2004-10-28
MXPA05010935A (es) 2005-11-25
US20200206147A1 (en) 2020-07-02
HK1079455A1 (zh) 2006-04-07
CN100450472C (zh) 2009-01-14
KR101052127B1 (ko) 2011-07-26
ZA200507034B (en) 2006-05-31
PT1615628E (pt) 2009-03-11
PL1615628T3 (pl) 2009-06-30
KR20050114724A (ko) 2005-12-06
RU2336866C2 (ru) 2008-10-27
CA2522962C (en) 2011-11-01
DE10317692A1 (de) 2004-11-11
US20070116751A1 (en) 2007-05-24
US10653636B2 (en) 2020-05-19
NZ543195A (en) 2009-04-30
US11426358B2 (en) 2022-08-30
ES2320550T3 (es) 2009-05-25
RU2005129528A (ru) 2006-05-10
DE502004008582D1 (de) 2009-01-15
WO2004091590A1 (de) 2004-10-28
BRPI0409889B8 (pt) 2021-05-25
CY1108832T1 (el) 2014-07-02
SI1615628T1 (sl) 2009-04-30
CN1826103A (zh) 2006-08-30

Similar Documents

Publication Publication Date Title
CY1108832T1 (el) Φαρμακευτικο εμπλαστρο δραστικης ουσιας με περιορισμενα οπτικα διακριτικα χαρακτηριστικα πανω στο δερμα
BR0102637A (pt) Curativo adesivo
DE69600065D1 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
BR0212026A (pt) Sistema terapêutico transdérmico com fentanila ou substâncias análogas
CL2004000674A1 (es) Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
ATE353655T1 (de) Myo-inositol hexaphosphat zur topischen verwendung
BRPI0407615A (pt) curativo trans-dérmico estável a uv
ATE387179T1 (de) Haltbare kosmetische zusammensetzung, die ein bestimmtes haftungsförderndes material enthält
CY1109726T1 (el) Δισκιο εγχρωμου πυρηνα
FR2716138B1 (fr) Produit composite laminé pelable et son application à la fabrication de cales de réglage.
HUP0302660A2 (hu) Rétegelt anyag testrészek védelmére és a rétegelt anyagot tartalmazó eszköz
AR002975A1 (es) Utilización de por lo menos un antagonista de cgrppara la preparaciónde una composición farmacéuticao dermatológica para tratar los pruritos, algias y/o disestesias oculares y/o palpebrales como asi tambien en una composición cosmética para ojos sensibles, composición obenida y procedimiento empleando dicha composición cosmética.
MX9403032A (es) Quinolil-dihidropiridinas condensadas, procedimiento para su fabricacion ysu uso en medicamentos.
DK0889721T3 (da) Lægemiddel til udvendig anvendelse og anvendelse af en vandig oliesmulsion til et sådant lægemiddel
CL2004001291A1 (es) Composicion farmaceutica que comprende compuestos carbociclicos y heterociclicos; y su uso para el tratamiento o profilaxis de la infeccion por influenza.
WO2003072606A3 (en) Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
ATE447978T1 (de) Kompresse für die kombinierte applikation von naturheilstoffen und elektromagnetischen strahlungen
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
ES2504365T3 (es) La actividad neuroprotectora de la proteína C activada es independiente de su actividad anticoagulante
Dyer Cholera epidemic threatens Sierra Leone.
HUP9600147A1 (hu) Molsidomint vagy metabolitját tartalmazó transzdermális gyógyszerforma és eljárás annak előállítására
Torres MCI in the clouds: The beauty of the clouds & terrain of the Grand Teton masks the obstacles rescuers faced in the response, care & transport of multiple victims of a lightning strike
Emerson Burnout Among Health Care Providers
ES2181160T3 (es) Derivados de 1,4-dihidropiridina y su utilizacion en terapia.